Strain identifier

BacDive ID: 1693

Type strain: Yes

Species: Bifidobacterium bifidum

Strain Designation: Ti

Strain history: DSM 20456 <-- T. Mitsuoka 4-127 <-- H. Tissier strain Ti.

NCBI tax ID(s): 500634 (strain), 1681 (species)

For citation purpose refer to the digital object identifier (doi) of the current version.
Archive
version 7 (current version):
version 6:
version 5:
version 4.1:
version 4:
version 3:
version 2.1:
version 2:
version 1:
version 7 (current version)

General

@ref: 8828

BacDive-ID: 1693

DSM-Number: 20456

keywords: mesophilic, anaerobe, Bacteria, 16S sequence, genome sequence

description: Bifidobacterium bifidum Ti is an anaerobe, mesophilic bacterium that was isolated from stool of breast-fed infant.

NCBI tax id

NCBI tax idMatching level
1681species
500634strain

strain history

doi: 10.13145/bacdive1693.20220920.7

Name and taxonomic classification

LPSN

  • @ref: 20215
  • description: domain/bacteria
  • keyword: phylum/actinomycetota
  • domain: Bacteria
  • phylum: Actinomycetota
  • class: Actinomycetes
  • order: Bifidobacteriales
  • family: Bifidobacteriaceae
  • genus: Bifidobacterium
  • species: Bifidobacterium bifidum
  • full scientific name: Bifidobacterium bifidum (Tissier 1900) Orla-Jensen 1924 (Approved Lists 1980)
  • synonyms

    @refsynonym
    20215Bacterium bifidum
    20215Bacillus bifidus

@ref: 8828

domain: Bacteria

phylum: Actinobacteria

class: Actinobacteria

order: Bifidobacteriales

family: Bifidobacteriaceae

genus: Bifidobacterium

species: Bifidobacterium bifidum

full scientific name: Bifidobacterium bifidum (Tissier 1900) Orla-Jensen 1924 emend. Nouioui et al. 2018

strain designation: Ti

type strain: yes

Culture and growth conditions

culture medium

@refnamegrowthlinkcomposition
8828BIFIDOBACTERIUM MEDIUM (DSMZ Medium 58)yeshttps://bacmedia.dsmz.de/medium/58Name: BIFIDOBACTERIUM MEDIUM (DSMZ Medium 58) Composition: Glucose 10.0 g/l Casein peptone 10.0 g/l Bacto Soytone 5.0 g/l Meat extract 5.0 g/l Yeast extract 5.0 g/l L-Cysteine HCl x H2O 0.5 g/l NaHCO3 0.4 g/l NaCl 0.08 g/l MnSO4 x H2O 0.05 g/l KH2PO4 0.04 g/l K2HPO4 0.04 g/l MgSO4 x 7 H2O 0.02 g/l CaCl2 x 2 H2O 0.01 g/l Tween 80 Resazurin Distilled water
35445MEDIUM 20 - for Anaerobic bacteriayesAgar (15.000 g);Glucose (5.000 g);Yeast extract (20.000 g);Tryptone (30.000 g);Cysteine hydrochloride (0.500 g);distilled water (1000.000 ml);Hemin solution -M00149 (25.000 ml)

culture temp

@refgrowthtypetemperaturerange
8828positivegrowth37mesophilic
35445positivegrowth37mesophilic
67770positivegrowth37mesophilic

Physiology and metabolism

oxygen tolerance

  • @ref: 8828
  • oxygen tolerance: anaerobe

murein

  • @ref: 8828
  • murein short key: A21.07
  • type: A4ß L-Orn-D-Ser-D-Asp

metabolite utilization

@refmetaboliteutilization activitykind of utilization testedChebi-ID
68371Potassium 2-ketogluconate-builds acid from
68371gluconate-builds acid from24265
68371L-arabitol-builds acid from18403
68371D-arabitol-builds acid from18333
68371L-fucose-builds acid from18287
68371D-fucose-builds acid from28847
68371D-tagatose-builds acid from16443
68371D-lyxose-builds acid from62318
68371turanose-builds acid from32528
68371gentiobiose-builds acid from28066
68371xylitol-builds acid from17151
68371glycogen-builds acid from28087
68371starch-builds acid from28017
68371raffinose-builds acid from16634
68371melezitose-builds acid from6731
68371inulin-builds acid from15443
68371trehalose-builds acid from27082
68371cellobiose-builds acid from17057
68371salicin-builds acid from17814
68371arbutin-builds acid from18305
68371amygdalin-builds acid from27613
68371N-acetylglucosamine-builds acid from59640
68371methyl alpha-D-glucopyranoside-builds acid from320061
68371methyl alpha-D-mannoside-builds acid from43943
68371D-sorbitol-builds acid from17924
68371D-mannitol-builds acid from16899
68371myo-inositol-builds acid from17268
68371galactitol-builds acid from16813
68371L-rhamnose-builds acid from62345
68371D-fructose+builds acid from15824
68371methyl beta-D-xylopyranoside-builds acid from74863
68371ribitol-builds acid from15963
68371L-xylose-builds acid from65328
68371D-xylose-builds acid from65327
68371D-ribose-builds acid from16988
68371L-arabinose-builds acid from30849
68371D-arabinose-builds acid from17108
68371erythritol-builds acid from17113
68371glycerol-builds acid from17754

API 50CHac

@refQGLYERYDARALARARIBDXYLLXYLADOMDXGALGLUFRUMNESBERHADULINOMANSORMDMMDGNAGAMYARBESCSALCELMALLACMELSACTREINUMLZRAFAMDGLYGXLTGENTURLYXTAGDFUCLFUCDARLLARLGNT2KG5KG
8828------------+------------+-----------------------+
8828----------+++------------+---++-------------------
8828----------++++/-+/-----------+--+/-+++/-------------------
8828----------+++------------+---++-------------------
8828----------+++------------+---++-------------------
8828----------+/-++----------------++/-------------------+/-

Isolation, sampling and environmental information

isolation

@refsample type
8828stool of breast-fed infant
67770Feces of a breast-fed infant

isolation source categories

Cat1Cat2Cat3
#Host#Human#Child
#Host Body Product#Gastrointestinal tract#Feces (Stool)

Safety information

risk assessment

  • @ref: 8828
  • biosafety level: 1
  • biosafety level comment: Risk group (German classification)

Sequence information

16S sequences

@refdescriptionaccessionlengthdatabaseNCBI tax ID
20218Bifidobacterium bifidum (ATCC 29521) 16S ribosomal RNA gene, partialM84777642ena1681
20218Bifidobacterium bifidum DSM 20456 16S ribosomal RNA gene, partial sequenceHM0075781344ena500634
20218Bifidobacterium bifidum DSM 20456 = JCM 1255 16S ribosomal RNA gene and 16S-23S ribosomal RNA intergenic spacer, partial sequenceJQ347252742ena500634
2021816S rRNA [Bifidobacterium bifidum, DSM 20456T, Genomic, 1532 nt]S836241532ena1681
20218Bifidobacterium bifidum gene for 16S rRNA, partial sequence, strain: JCM 1255AB116283477ena500634
20218Bifidobacterium bifidum gene for 16S rRNA, partial sequence, strain: JCM 1255AB507078668ena500634
20218Bifidobacterium bifidum strain KCTC 3202 16S ribosomal RNA gene, partial sequenceGU3618131480ena1681
20218Bifidobacterium bifidum strain KCTC 3202 16S ribosomal RNA gene, partial sequenceU259511488ena1681
20218Bifidobacterium bifidum KCTC 3202 16S rRNA geneU259521488ena1681
20218Bifidobacterium bifidum gene for 16S rRNA, partial sequence, strain: NBRC 100015AB6811291453ena1681
67770Bifidobacterium bifidum gene for 16S ribosomal RNA, partial sequenceAB4373561519ena1681
67770B.bifidum small subunit ribosomal RNA geneM380181532ena500634

Genome sequences

@refdescriptionaccessionassembly leveldatabaseNCBI tax ID
66792Bifidobacterium bifidum NCTC13001GCA_900637095completencbi1681
66792Bifidobacterium bifidum ATCC 29521 = JCM 1255 = DSM 20456 JCM 1255GCA_001025135completencbi500634
66792Bifidobacterium bifidum LMG 11041GCA_000741085contigncbi1681
66792Bifidobacterium bifidum ATCC 29521 = JCM 1255 = DSM 20456 DSM 20456GCA_000771485contigncbi500634
66792Bifidobacterium bifidum ATCC 29521 = JCM 1255 = DSM 20456 ATCC 29521GCA_000466525scaffoldncbi500634
66792Bifidobacterium bifidum ATCC 29521 = JCM 1255 = DSM 20456 Bifidobacterium_bifidum_MC1GCA_901212485scaffoldncbi500634
66792Bifidobacterium bifidum ATCC 29521 = JCM 1255500634.3wgspatric500634
66792Bifidobacterium bifidum ATCC 29521 = JCM 1255 = DSM 20456500634.6completepatric500634
66792Bifidobacterium bifidum ATCC 29521 = JCM 1255 = DSM 20456500634.4wgspatric500634
66792Bifidobacterium bifidum ATCC 29521 = JCM 1255 = DSM 20456 strain Bifidobacterium_bifidum_MC1500634.12wgspatric500634
66792Bifidobacterium bifidum strain LMG 110411681.23wgspatric1681
66792Bifidobacterium bifidum strain NCTC130011681.149completepatric1681
66792Bifidobacterium bifidum LMG 110412597490229draftimg1681
66792Bifidobacterium bifidum ATCC 295212848061456completeimg500634
66792Bifidobacterium bifidum ATCC 295212700989374draftimg500634
66792Bifidobacterium bifidum ATCC 295212541047090draftimg500634
67770Bifidobacterium bifidum ATCC 29521 = JCM 1255 = DSM 20456 DNA, complete genomeAP012323ena500634
67770Bifidobacterium bifidum ATCC 29521 = JCM 1255 = DSM 20456 strain ATCC 29521, whole genome shotgun sequencing projectAWSW00000000ncbi500634
67770Bifidobacterium bifidum ATCC 29521 = JCM 1255 = DSM 20456, whole genome shotgun sequencing projectJDUM00000000ncbi500634
67770Bifidobacterium bifidum strain LMG 11041, whole genome shotgun sequencing projectJGYO00000000ncbi1681

External links

@ref: 8828

culture collection no.: DSM 20456, ATCC 29521, JCM 1255, BCRC 11845, BCRC 14615, CCUG 18364, CCUG 45217, CECT 870, CGMCC 1.2212, CIP 56.7, HAMBI 1380, IFO 14252, KCTC 3202, KCTC 3281, LMG 11041, LMG 8810, NBRC 100015, NBRC 14252, NCAIM B.02021, NCFB 2715, NCIMB 702715, NCTC 13001, VTT E-97795

straininfo link

@refpassport
20218http://www.straininfo.net/strains/5383
20218http://www.straininfo.net/strains/5377
20218http://www.straininfo.net/strains/5385

literature

topicPubmed-IDtitleauthorsjournalDOIyearmeshtopic2
Phylogeny1371060Phylogenetic evidence for the transfer of Eubacterium suis to the genus Actinomyces as Actinomyces suis comb. nov.Ludwig W, Kirchhof G, Weizenegger M, Weiss NInt J Syst Bacteriol10.1099/00207713-42-1-1611992Actinomyces/*classification/genetics, Base Sequence, Eubacterium/*classification/genetics, Molecular Sequence Data, RNA, Bacterial/*chemistry, RNA, Ribosomal, 16S/*chemistryGenetics
Metabolism1908865Binding of mutagens by fractions of the cell wall skeleton of lactic acid bacteria on mutagens.Zhang XB, Ohta YJ Dairy Sci10.3168/jds.S0022-0302(91)78306-91991Bifidobacterium/*metabolism, Cell Wall/metabolism, Humans, Lactobacillus acidophilus/*metabolism, Lactococcus lactis/metabolism/ultrastructure, Mutagens/*metabolism, Neoplasms/*prevention & control, Streptococcus/*metabolism/ultrastructurePathogenicity
Metabolism2071710In vitro binding of mutagenic pyrolyzates to lactic acid bacterial cells in human gastric juice.Zhang XB, Ohta YJ Dairy Sci10.3168/jds.S0022-0302(91)78221-01991Calcium Chloride/pharmacology, Carbolines/*metabolism, Freeze Drying, Gastric Juice/*microbiology, Hot Temperature, Humans, Hydrogen-Ion Concentration, Imidazoles/*metabolism, Magnesium Chloride/pharmacology, Mutagens/*metabolism, Sodium Chloride/pharmacology, Streptococcus/growth & development/*metabolismStress
Enzymology7745146Viability and enzymatic activity of bifidobacteria in milk.Hughes DB, Hoover DGJ Dairy Sci10.3168/jds.S0022-0302(95)76634-61995Animals, Bifidobacterium/*enzymology/*growth & development, Cold Temperature, Freezing, Milk/*microbiology, alpha-Galactosidase/*metabolismMetabolism
Transcriptome10510720Sequence analysis of 16S rRNA genes amplified from two ribosomal RNA gene clusters of Bifidobacterium bifidum.Yoon JH, Yim DK, Goodfellow M, Park YHAntonie Van Leeuwenhoek10.1023/a:10020251004441999Bifidobacterium/*genetics, Blotting, Southern, DNA, Ribosomal/chemistry, Polymerase Chain Reaction, RNA, Bacterial/*chemistry, RNA, Ribosomal, 16S/*chemistry, Sequence Analysis, DNAPhylogeny
Enzymology15606767Molecular identification of monomeric aspartate racemase from Bifidobacterium bifidum.Yamashita T, Ashiuchi M, Ohnishi K, Kato S, Nagata S, Misono HEur J Biochem10.1111/j.1432-1033.2004.04445.x2004Amino Acid Isomerases/chemistry/isolation & purification/*metabolism, Amino Acid Sequence, Base Sequence, Bifidobacterium/*enzymology, Cloning, Molecular, DNA Primers, Electrophoresis, Polyacrylamide Gel, Enzyme Stability, Hydrogen-Ion Concentration, Kinetics, Molecular Sequence Data, Molecular Weight, Recombinant Proteins/chemistry/isolation & purification/metabolism, Sequence Homology, Amino Acid, Substrate SpecificityPhylogeny
Pathogenicity15960982Molecular properties and prebiotic effect of inulin obtained from artichoke (Cynara scolymus L.).Lopez-Molina D, Navarro-Martinez MD, Rojas Melgarejo F, Hiner AN, Chazarra S, Rodriguez-Lopez JNPhytochemistry10.1016/j.phytochem.2005.04.0032005Bifidobacterium/drug effects/*growth & development, Cynara scolymus/*chemistry, Feces/microbiology, Gas Chromatography-Mass Spectrometry, Humans, Infant, Inulin/chemistry/*isolation & purification/pharmacology, Molecular Weight, Plant Extracts/isolation & purification/pharmacology, Polymers, Spectroscopy, Fourier Transform InfraredEnzymology
Pathogenicity17387552Basic characteristics of Sporolactobacillus inulinus BCRC 14647 for potential probiotic properties.Huang HY, Huang SY, Chen PY, King VA, Lin YP, Tsen JHCurr Microbiol10.1007/s00284-006-0496-52007Acids/pharmacology, Bacillaceae/drug effects/*physiology, Bacterial Adhesion, Bifidobacterium/physiology, Bile Acids and Salts/pharmacology, Caco-2 Cells, Humans, Hydrogen-Ion Concentration, Lactobacillaceae, Lactobacillus acidophilus/physiology, Microbial Viability, *Probiotics, Spores, Bacterial/physiology
Pathogenicity17993372Incorporation of citrus fibers in fermented milk containing probiotic bacteria.Sendra E, Fayos P, Lario Y, Fernandez-Lopez J, Sayas-Barbera E, Perez-Alvarez JAFood Microbiol10.1016/j.fm.2007.09.0032007Animals, Bifidobacterium/*growth & development, Citrus/*chemistry, Colony Count, Microbial, Fermentation, Food Handling/methods, Food Preservation/*methods, Humans, Lactobacillus acidophilus/*growth & development, Lactobacillus casei/*growth & development, Milk/*microbiology, Models, Biological, Probiotics, Time Factors
Metabolism23332852Antimicrobial potential for the combination of bovine lactoferrin or its hydrolysate with lactoferrin-resistant probiotics against foodborne pathogens.Chen PW, Jheng TT, Shyu CL, Mao FCJ Dairy Sci10.3168/jds.2012-61122013Animals, Anti-Infective Agents/administration & dosage/*therapeutic use, Bifidobacterium/metabolism, Cattle, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Lactobacillus/metabolism, Lactobacillus acidophilus/metabolism, Lactobacillus rhamnosus/metabolism, Lactoferrin/administration & dosage/drug effects/*therapeutic use, Pediococcus/metabolism, Probiotics/administration & dosage/*therapeutic use, Protein Hydrolysates, Salmonella typhimurium/drug effectsPathogenicity
Metabolism24014530BopA does not have a major role in the adhesion of Bifidobacterium bifidum to intestinal epithelial cells, extracellular matrix proteins, and mucus.Kainulainen V, Reunanen J, Hiippala K, Guglielmetti S, Vesterlund S, Palva A, Satokari RAppl Environ Microbiol10.1128/AEM.01993-132013*Bacterial Adhesion, Bacterial Proteins/genetics/*metabolism, Bifidobacterium/genetics/*physiology, Caco-2 Cells, Cell Membrane, Cloning, Molecular, Epithelial Cells/*microbiology, Escherichia coli/genetics/metabolism, Extracellular Matrix Proteins/metabolism, Genes, Bacterial, HT29 Cells, Humans, Intestinal Mucosa/*cytology/microbiology, Lipoproteins/genetics/metabolism, Membrane Proteins/genetics/*metabolism, Mucus/microbiology, Probiotics, Protein Binding, Recombinant Proteins/genetics/metabolismEnzymology
Pathogenicity24916115Influence of bovine lactoferrin on the growth of selected probiotic bacteria under aerobic conditions.Chen PW, Ku YW, Chu FYBiometals10.1007/s10534-014-9758-z2014Aerobiosis, Anaerobiosis, Animals, Anti-Bacterial Agents/administration & dosage, Antimicrobial Cationic Peptides/administration & dosage/physiology, Bifidobacterium/drug effects/growth & development, Cattle, Escherichia coli/drug effects/growth & development/pathogenicity, Lactobacillus/drug effects/growth & development, Lactoferrin/*administration & dosage/*physiology, Microbial Sensitivity Tests, Probiotics/*administration & dosage
Pathogenicity25099661Fourier transform infra-red spectroscopy and flow cytometric assessment of the antibacterial mechanism of action of aqueous extract of garlic (Allium sativum) against selected probiotic Bifidobacterium strains.Booyens J, Thantsha MSBMC Complement Altern Med10.1186/1472-6882-14-2892014Anti-Bacterial Agents/chemistry/*pharmacology, Bifidobacterium/*drug effects, Flow Cytometry/methods, Garlic/*chemistry, Microbial Viability/drug effects, Plant Extracts/chemistry/*pharmacology, *Probiotics, Spectroscopy, Fourier Transform Infrared/methods
25276184Microencapsulation of Probiotics by Calcium Alginate-gelatinized Starch with Chitosan Coating and Evaluation of Survival in Simulated Human Gastro-intestinal Condition.Khosravi Zanjani MA, Ghiassi Tarzi B, Sharifan A, Mohammadi NIran J Pharm Res2014
25866754A Novel Lactobacillus casei LP1 Producing 1,4-Dihydroxy-2-Naphthoic Acid, a Bifidogenic Growth Stimulator.Kang JE, Kim TJ, Moon GSPrev Nutr Food Sci10.3746/pnf.2015.20.1.782015
Genetics26133927Complete genome sequence of Bifidobacterium bifidum JCM 1255(T) isolated from feces of a breast-fed infant.Morita H, Toh H, Oshima K, Nakano A, Shindo C, Komiya K, Arakawa K, Suda W, Honda K, Hattori MJ Biotechnol10.1016/j.jbiotec.2015.06.4132015Base Composition, Bifidobacterium/*genetics, Breast Feeding, Feces/*microbiology, Genome Size, *Genome, Bacterial, Humans, Infant, Molecular Sequence Annotation, Molecular Sequence Data, Sequence Analysis, DNA/*methodsPathogenicity
Pathogenicity26863255Efficacy of oral Bifidobacterium bifidum ATCC 29521 on microflora and antioxidant in mice.Wang BG, Xu HB, Xu F, Zeng ZL, Wei HCan J Microbiol10.1139/cjm-2015-06852015Animals, Antioxidants/*pharmacology, *Bifidobacterium, *Gastrointestinal Microbiome, Humans, Male, Mice, Mice, Inbred BALB C, Mouth/*microbiology, Oxidative Stress
Pathogenicity27018325Effect of oligosaccharides on the adhesion of gut bacteria to human HT-29 cells.Altamimi M, Abdelhay O, Rastall RAAnaerobe10.1016/j.anaerobe.2016.03.0102016Bacterial Adhesion/*drug effects, Bacteroides/drug effects/physiology, Bacteroides fragilis/drug effects/physiology, Bifidobacterium/drug effects/physiology, Clostridium/drug effects/physiology, Faecalibacterium/drug effects/physiology, Gastrointestinal Microbiome/*drug effects, HT29 Cells, Humans, Lactobacillus casei/drug effects/physiology, Mucins/metabolism, Oligosaccharides/*pharmacology, Prebiotics/*analysis, Species SpecificityPhylogeny
Pathogenicity27372578Integration of genomic and proteomic data to identify candidate genes in HT-29 cells after incubation with Bifidobacterium bifidum ATCC 29521.Wang BG, Wu Y, Qiu L, Shah NP, Xu F, Wei HJ Dairy Sci10.3168/jds.2015-105772016Animals, Bifidobacterium bifidum/*growth & development, Caco-2 Cells, Databases, Genetic, Down-Regulation, Epithelial Cells/*metabolism/microbiology, Gastrointestinal Microbiome, Gene Ontology, HT29 Cells, Humans, Intestines/cytology/microbiology, Mice, Mice, Inbred BALB C, Probiotics, *Proteome, Proteomics, Reproducibility of Results, Up-RegulationProteome
Metabolism29120775Preparation and prebiotic potential of pectin oligosaccharides obtained from citrus peel pectin.Zhang S, Hu H, Wang L, Liu F, Pan SFood Chem10.1016/j.foodchem.2017.10.0712017Bifidobacterium/drug effects/growth & development/metabolism, Hydrogen Peroxide/metabolism, Monosaccharides/analysis, Oligosaccharides/chemistry/*pharmacology, Pectins/*chemistry, *PrebioticsPathogenicity
Phylogeny29300153Bifidobacterium catulorum sp. nov., a novel taxon from the faeces of the baby common marmoset (Callithrix jacchus).Modesto M, Michelini S, Oki K, Biavati B, Watanabe K, Mattarelli PInt J Syst Evol Microbiol10.1099/ijsem.0.0025452018Aldehyde-Lyases/genetics, Animals, Bacterial Typing Techniques, Base Composition, Bifidobacterium/*classification/genetics/isolation & purification, Callithrix/*microbiology, Chaperonin 60/genetics, DNA, Bacterial/genetics, Feces/microbiology, Genes, Bacterial, Peptidoglycan/chemistry, *Phylogeny, RNA, Ribosomal, 16S/genetics, Sequence Analysis, DNATranscriptome
29881432Promoting Probiotics Survival by Microencapsualtion with Hylon Starch and Genipin Cross-linked Coatings in Simulated Gastro-intestinal Condition and Heat Treatment.Khosravi Zanjani MA, Ehsani MR, Ghiassi Tarzi B, Sharifan AIran J Pharm Res2018
Phylogeny30789326Characterization of the phylogenetic diversity of five novel species belonging to the genus Bifidobacterium: Bifidobacterium castoris sp. nov., Bifidobacterium callimiconis sp. nov., Bifidobacterium goeldii sp. nov., Bifidobacterium samirii sp. nov. and Bifidobacterium dolichotidis sp. nov.Duranti S, Lugli GA, Napoli S, Anzalone R, Milani C, Mancabelli L, Alessandri G, Turroni F, Ossiprandi MC, van Sinderen D, Ventura MInt J Syst Evol Microbiol10.1099/ijsem.0.0033062019Animals, Bacterial Typing Techniques, Base Composition, Bifidobacterium/*classification, Callithrix/*microbiology, DNA, Bacterial/genetics, Feces/microbiology, Genes, Bacterial, *Phylogeny, RNA, Ribosomal, 16S/genetics, Rodentia/*microbiology, Saimiri/*microbiology, Sequence Analysis, DNATranscriptome
Metabolism30880149Purified thioredoxin reductase from O2-sensitive Bifidobacterium bifidum degrades H2O2 by interacting with alkyl hydroperoxide reductase.Satoh T, Todoroki M, Kobayashi K, Niimura Y, Kawasaki SAnaerobe10.1016/j.anaerobe.2019.03.0122019Anaerobiosis, Bifidobacterium bifidum/*enzymology/metabolism, Hydrogen Peroxide/*metabolism, Oxidants/*metabolism, Oxygen/metabolism/toxicity, Peroxiredoxins/*metabolism, Thioredoxin-Disulfide Reductase/isolation & purification/*metabolismEnzymology
Pathogenicity31965845Analysis of hypoxia-associated dendritic cells in colitic mice and effects of probiotics on IL-10 production in inflammatory dendritic-cells under hypoxia.Ogita T, Miyamoto J, Hirabayashi Y, Rossi M, Mazzarella G, Takahashi I, Tanabe S, Suzuki TBenef Microbes10.3920/BM2018.01712019Animals, Cell Differentiation, Cells, Cultured, Colitis/chemically induced, Colon/pathology, Dendritic Cells/immunology/*pathology, Female, Hypoxia/chemically induced/*immunology, Hypoxia-Inducible Factor 1, alpha Subunit/genetics, *Inflammation, Interleukin-10/*biosynthesis, Lymph Nodes/immunology/pathology, Mice, Mice, Inbred BALB C, Mucous Membrane/immunology/pathology, Oxygen/*metabolism, *ProbioticsBiotechnology
Phylogeny32065574Characterization of the phylogenetic diversity of two novel species belonging to the genus Bifidobacterium: Bifidobacterium cebidarum sp. nov. and Bifidobacterium leontopitheci sp. nov.Duranti S, Lugli GA, Viappiani A, Mancabelli L, Alessandri G, Anzalone R, Longhi G, Milani C, Ossiprandi MC, Turroni F, Ventura MInt J Syst Evol Microbiol10.1099/ijsem.0.0040322020Aldehyde-Lyases, Animals, Bacterial Typing Techniques, Base Composition, Base Sequence, Bifidobacterium/*classification/isolation & purification, Callimico/*microbiology, DNA, Bacterial/genetics, Fatty Acids/chemistry, Feces/microbiology, Genes, Bacterial, Leontopithecus/*microbiology, Peptidoglycan/chemistry, *Phylogeny, RNA, Ribosomal, 16S/genetics, Sequence Analysis, DNATranscriptome
Metabolism32145470Inhibitory effect of Bifidobacterium bifidum ATCC 29521 on colitis and its mechanism.Din AU, Hassan A, Zhu Y, Zhang K, Wang Y, Li T, Wang Y, Wang GJ Nutr Biochem10.1016/j.jnutbio.2020.1083532020Animals, Anti-Inflammatory Agents/pharmacology, Antioxidants/pharmacology, *Bifidobacterium bifidum, Colitis, Ulcerative/chemically induced/*drug therapy/metabolism, Colon/metabolism, Cytokines/metabolism, Dextran Sulfate/adverse effects, Disease Models, Animal, Dysbiosis/chemically induced/drug therapy, Gastrointestinal Microbiome/drug effects, Interleukin-1beta/metabolism, Male, Mice, Mice, Inbred C57BL, MicroRNAs/metabolism, NF-kappa B/metabolism, Probiotics/administration & dosage/*pharmacology, Tumor Necrosis Factor-alpha/metabolismPathogenicity
Metabolism33233577Utilization of Seafood Processing By-Products for Production of Proteases by Paenibacillus sp. TKU052 and Their Application in Biopeptides' Preparation.Doan CT, Tran TN, Nguyen VB, Nguyen AD, Wang SLMar Drugs10.3390/md181105742020Angiotensin-Converting Enzyme Inhibitors/metabolism/pharmacology, Animal Shells, Animals, Antioxidants/metabolism/pharmacology, Bacterial Proteins/isolation & purification/*metabolism, *Brachyura, Enzyme Stability, Fermentation, *Food Handling, *Industrial Microbiology, Paenibacillus/*enzymology, Peptide Hydrolases/isolation & purification/*metabolism, Peptides/*metabolism, Prebiotics, Proteolysis, *Seafood, Substrate Specificity, *Waste ProductsEnzymology
Phylogeny33686049Effects of Pretreatment with Bifidobacterium bifidum Using 16S Ribosomal RNA Gene Sequencing in a Mouse Model of Acute Colitis Induced by Dextran Sulfate Sodium.Weng YJ, Jiang DX, Liang J, Ye SC, Tan WK, Yu CY, Zhou YMed Sci Monit10.12659/MSM.9284782021Animals, Bacteria/genetics, Bifidobacterium bifidum/*metabolism, Colitis/*drug therapy/microbiology, Colitis, Ulcerative/genetics, Colon/pathology, Dextran Sulfate/adverse effects/pharmacology, Disease Models, Animal, Feces/microbiology, Female, Gastrointestinal Microbiome/*drug effects/genetics, Inflammatory Bowel Diseases/pathology, Mice, Mice, Inbred C57BL, Probiotics/therapeutic use, RNA, Ribosomal, 16S/geneticsMetabolism
34663045In vitro prebiotic evaluation of exopolysaccharides produced by marine isolated lactic acid bacteria.Hongpattarakere T, Cherntong N, Wichienchot S, Kolida S, Rastall RACarbohydr Polym10.1016/j.carbpol.2011.08.0852011

Reference

@idauthorscataloguedoi/urltitlejournalpubmed
8828Curators of the DSMZLeibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 20456)https://www.dsmz.de/collection/catalogue/details/culture/DSM-20456
20215Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.10.1099/ijsem.0.004332List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ
20218Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.10.1016/j.syapm.2013.11.002StrainInfo introduces electronic passports for microorganisms.Syst Appl Microbiol. 37: 42-50 201424321274
35445Curators of the CIPhttps://brclims.pasteur.fr/brcWeb/souche/detail/1/9010
66792Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmannhttps://diaspora-project.de/progress.html#genomesAutomatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)
67770Curators of the JCMhttps://jcm.brc.riken.jp/en/
68371Automatically annotated from API 50CH acid